Cargando…
Association of Diphtheria-Tetanus–Acellular Pertussis Vaccine Timeliness and Number of Doses With Age-Specific Pertussis Risk in Infants and Young Children
IMPORTANCE: In most countries, the diphtheria-tetanus–acellular pertussis (DTaP) vaccine is administered as a 3-dose infant series followed by additional booster doses in the first 5 years of life. Short-term immunity from the DTaP vaccine can depend on the number, timing, and interval between doses...
Autores principales: | Rane, Madhura S., Rohani, Pejman, Halloran, M. Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356064/ https://www.ncbi.nlm.nih.gov/pubmed/34374773 http://dx.doi.org/10.1001/jamanetworkopen.2021.19118 |
Ejemplares similares
-
Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine
por: Decker, Michael D., et al.
Publicado: (2015) -
Tetanus–diphtheria–acellular pertussis vaccination for adults: an update
por: Lee, Hyo-Jin, et al.
Publicado: (2017) -
Association between pertussis vaccination coverage and other sociodemographic factors and pertussis incidence using surveillance data
por: Rane, Madhura S., et al.
Publicado: (2023) -
The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies
por: Abu-Raya, Bahaa, et al.
Publicado: (2019) -
Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and
Acellular Pertussis Vaccination
por: Hansen, John, et al.
Publicado: (2021)